Debra BorchardtJuly 11, 2023
Psychedelic drug company Bright Minds Biosciences Inc. (CSE: DRUG) (NASDAQ: DRUG) has set the date to consolidate its common shares on a five to one basis in order to boost its share price and regain compliance with the Nasdaq. The company’s post-consolidation shares are expected to begin trading on the Canadian Securities Exchange and The […]
